MYOV
Income statement / Annual
Last year (2022), Myovant Sciences Ltd.'s total revenue was $230.97 M,
an increase of 289.39% from the previous year.
In 2022, Myovant Sciences Ltd.'s net income was -$205.98 M.
See Myovant Sciences Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
| Operating Revenue |
$230.97 M
|
$59.32 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$51.55 M |
$1.97 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$179.42 M |
$57.35 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.78 |
0.97 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$107.40 M
|
$136.71 M
|
$192.56 M
|
$222.61 M
|
$116.83 M
|
$43.50 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$82.33 M
|
$42.22 M
|
$24.23 M
|
$12.36 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$259.36 M
|
$181.42 M
|
$82.33 M
|
$42.22 M
|
$24.23 M
|
$12.36 M
|
| Other Expenses |
$40.04 M |
$1.66 M |
$1.62 M |
-$309,000.00 |
$67,000.00 |
-$139,000.00 |
| Operating Expenses |
$366.77 M |
$318.14 M |
$274.89 M |
$264.83 M |
$141.06 M |
$55.86 M |
| Cost And Expenses |
$418.32 M |
$320.10 M |
$274.89 M |
$264.83 M |
$141.06 M |
$55.86 M |
| Interest Income |
$384,000.00 |
$211,000.00 |
$2.55 M |
$881,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$13.97 M |
$10.40 M |
$12.66 M |
$8.82 M |
$2.05 M |
$0.00 |
| Depreciation &
Amortization |
$3.46 M
|
$2.69 M
|
$1.77 M
|
$438,000.00
|
$243,000.00
|
$61,000.00
|
| EBITDA |
-$183.89 M
|
-$258.09 M
|
-$273.80 M
|
-$255.88 M
|
-$140.75 M
|
$0.00
|
| EBITDA Ratio |
-0.8 |
-4.35 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-0.81
|
-4.4
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$13.59 M
|
$5.99 M
|
-$17.51 M
|
-$8.25 M
|
-$1.98 M
|
-$27.66 M
|
| Income Before Tax |
-$200.93 M |
-$254.80 M |
-$288.23 M |
-$273.08 M |
-$143.04 M |
-$83.51 M |
| Income Before Tax Ratio
|
-0.87
|
-4.3
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$5.05 M |
$336,000.00 |
$761,000.00 |
$476,000.00 |
$213,000.00 |
-$74,000.00 |
| Net Income |
-$205.98 M |
-$255.13 M |
-$288.99 M |
-$273.55 M |
-$143.26 M |
-$83.44 M |
| Net Income Ratio |
-0.89 |
-4.3 |
0 |
0 |
0 |
0 |
| EPS |
-2.22 |
-2.83 |
-3.37 |
-4.09 |
-2.41 |
-1.7 |
| EPS Diluted |
-2.22 |
-2.83 |
-3.37 |
-4.09 |
-2.41 |
-1.7 |
| Weighted Average Shares
Out |
$92.97 M
|
$90.04 M
|
$85.84 M
|
$66.91 M
|
$59.52 M
|
$49.18 M
|
| Weighted Average Shares
Out Diluted |
$92.97 M
|
$90.04 M
|
$85.84 M
|
$66.91 M
|
$59.52 M
|
$49.18 M
|
| Link |
|
|
|
|
|
|
